Organic Process Research and Development p. 1918 - 1925 (2019)
Update date:2022-08-04
Topics:
Wang, Cuiling
Bai, Xiao
Wang, Rui
Zheng, Xudong
Ma, Xiumei
Chen, Huan
Ai, Yun
Bai, Yajun
Liu, Yifeng
A new method for imatinib synthesis is described by using the C-N coupling reaction of 4-(4-methylpiperazine-1-methyl)benzamide with N-(5-bromo-2-tolyl)-4-(3-pyridyl)pyrimidin-2-amine to form imatinib. In this synthetic route, the high efficiency and high selectivity of nano-ZnO as a catalyst is key to the mild hydrolysis of 4-(4-methylpiperazine-1-methyl)benzonitrile into the corresponding amide. The total imatinib yield was 51.3%, and the purity was 99.9%. This simple and effective synthetic pathway avoids gene-impurity production (as classified by the FDA Center for Drug Evaluation and Research), and the synthesis is environmentally friendly with a short reaction time.
View Morewebsite:http://www.u-chemo.com
Contact:+86-21-61558312
Address:Dong Fang Road,
Sichuan WeiKeqi Biological Technology Co., Ltd.
Contact:86-028-81700200
Address:sichuan Chengdu Qingjiang Zhonglu 63号
YingYing Pharmaceutical Co.,Ltd
Contact:86-18854126208
Address:55#, yingxiongshan road
Anhui Sunsing Chemicals Co.,Ltd
website:http://www.sunsingchem.com
Contact:0086-566-2023179
Address:Jin An industry park, Chizhou economic technical development zone, Anhui
Chongqing Yawei Fine Chemical Co.,Ltd
Contact:0086-23-62849407
Address:Ziyou village, Nanquan town, Banan district, Chongqing China
Doi:10.1021/jo902512q
(2010)Doi:10.1016/j.tetlet.2009.11.094
(2010)Doi:10.1021/ol902711b
(2010)Doi:10.1016/j.bmcl.2009.11.014
(2010)Doi:10.1002/cmdc.200900394
(2010)Doi:10.1016/S0022-328X(00)98602-9
(1983)